Phage susceptibility testing methods or 'phagograms': where do we stand and where should we go?
Camille Kolenda1,2, Julie Jourdan1, Tiphaine Roussel-Gaillard1
1Service de bactériologie, Institut des Agents Infectieux, Hospices Civils de Lyon, Lyon, France.
The Journal of Antimicrobial Chemotherapy
|September 13, 2024
Summary
Phage therapy offers a promising solution to antimicrobial resistance. This review details phage susceptibility testing (PST) methods, highlighting the need for standardization and automation for effective phage selection.
Area of Science:
- Microbiology
- Biotechnology
- Infectious Diseases
Background:
- Antimicrobial resistance (AMR) is a growing global health threat.
- Phage therapy, using bacteriophages to treat bacterial infections, is a viable alternative.
- Phage susceptibility testing (PST) is crucial for selecting effective phages due to their specificity.
Purpose of the Study:
- To review current phage susceptibility testing (PST) methods.
- To identify challenges and limitations in existing PST techniques.
- To highlight the need for standardized and automated PST for clinical application.
Main Methods:
- Description of plaque assays and growth kinetic assays for PST.
- Analysis of the principles, advantages, and disadvantages of each method.
- Discussion of labor-intensive and time-consuming aspects of current PST.
Main Results:
- Plaque and growth kinetic assays are routinely used but are labor-intensive.
- Current PST methods require automation for efficiency in preparation, incubation, reading, and analysis.
- A standardized reference method for PST is urgently needed.
Conclusions:
- Standardization and automation are critical for efficient phage selection in phage therapy.
- Further research is needed to address knowledge gaps and establish a reference PST method.
- Developing efficient PST techniques will facilitate the clinical application of phage therapy.


